Media releases are provided as is by companies and have not been edited or checked for accuracy. Any queries should be directed to the company itself.
  • 18 July 2019 21:45

Clinical Trials Market By Phases, Study Design, Indications/Symptoms, And Region - Global Forecast To 2028

Clinical Trials Market By Phases (Phase I, Phase II, Phase III, And Other), By Study Design (Interventional Trials, Observational Trials, And Other), By Indications/Symptoms (Cancer, Circulatory, CNS, And Others) And Region - Global Forecast To 2028

Global Clinical Trials Market: Introduction

Clinical trials are type of research studies, conducted on individuals who volunteered for testing medical equipment or drugs in order to determine treatment for certain diseases or disorders. They are conducted in order to diagnose, detect, prevent various types of diseases. Each clinical trials have certain protocols and action plan to execute the testing procedure. Clinical trials help to generate data regarding efficiency, effectiveness, and safety of drugs and medical treatments on animals and humans. The global Clinical Trials Market is estimated to value at nearly US$ 44 Bn in 2019, and is expected to register a CAGR of 5.7%.

Global Clinical Trials Market: Dynamics

Increasing demand for new medical equipments and medicines among end users, coupled with growing investment for research and development activities for development of effective medicines are major factors driving growth of the global clinical trials market. In addition, increasing number of individuals suffering from chronic diseases as well as changing conditions and nature of certain types of chronic diseases is another factor anticipated to support growth of the global clinical trials market to significant extent.

Furthermore, increasing prevalence of neurological diseases such as Parkinson’s, Alzheimer’s, tumors, depression, epilepsy, coupled with growing geriatric population are also factors expected to drive growth of the target market over the forecast period. Increasing clinical trials for finding effective and permanent solutions to cure or slowdown and prevent spread of neurological diseases and aging diseases is a factor propelling growth of the target market.

Analysis By Segmentation:

The market report has been segmented on the basis of phases, study design, indications/symptoms, and region. The phases segment includes phase I, phase II, phase III, and phase IV. The study design segment includes interventional trials, observational trials, and expanded access trials. The indications/symptoms segment includes autoimmune, blood disorders, cancer, circulatory, CNS, congenital, CVS, dermatology, ear, gastrointestinal, genitourinary, infections, mental disorders, metabolic, musculoskeletal, nose, ophthalmology, and others. The region includes the North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

By Phases:

The Phase II segment is expected to register highest CAGR of over 5.8% over the forecast period in the global market

By Study Design:

The interventional trials segment is expected to register highest CAGR of over 5.5% over the next 10 years

By Indications/Symptoms:

The cancer segment is expected to register highest CAGR of over 6% over the forecast period in the global market

By Region:

The market in Asia Pacific is expected to register highest CAGR of over 6% in the global clinical trials market

Global Clinical Trials Market: Competitive Analysis

The research report on the global clinical trials market includes profiles of some of the major companies such as Eli Lilly and Company, Sun Pharmaceutical Industries Ltd., Novo Nordisk A/S, Pfizer Inc., ICON plc, Sanofi, Laboratory Corporation of America Holdings, F. Hoffmann-La Roche Ltd., PAREXEL International Corporation, and IQVIA Holdings Inc.

The Global Clinical Trials Market: Global Industry, Size, Share, Growth, Trends, and Forecast, 2019–2028 report has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the present scenario and the growth prospects of the global clinical trials market for 2018–2028.

About Us: is a specialized market research, analytics, and solutions company, offering strategic and tactical support to clients for making well-informed business decisions. We are a team of dedicated and impassioned individuals, who believe strongly in giving our very best to what we do and we never back down from any challenge. offers services such as data mining, information management, and revenue enhancement solutions and suggestions. We cater to industries, individuals, and organizations across the globe, and deliver our offerings in the shortest possible turnaround time.

Contact Us:

Lawrence John

420 Lexington Avenue, Suite 300 New York City, NY 10170, United States

Email ID:

Tel: +1 347 826 1876


Submit a media release

Editor's Recommendations

Brand Page


View all events Submit your own security event

Latest Videos

More videos

Blog Posts

Media Release

More media release